+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gatifloxacin Market by Product Type, Application, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Gatifloxacin Market by Product Type, Application, Route of Administration, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Gatifloxacin Market by Product Type, Application, Route of Administration, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967939
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In a landscape where antimicrobial innovation and resistance continue to challenge healthcare systems, the gatifloxacin market represents a dynamic sector for senior leaders seeking informed, actionable insights. Evolving clinical needs, regulatory changes, and emerging technologies are shaping its progression, demanding robust strategy and timely adaptation.

Market Snapshot: Gatifloxacin Market Growth Trajectory

The gatifloxacin market grew from USD 331.32 million in 2024 to USD 348.23 million in 2025. It is expected to continue growing at a CAGR of 4.86%, reaching USD 440.68 million by 2030. This steady growth reflects the combined influence of evolving resistance patterns, manufacturing advancements, and a global push toward specialized antimicrobial therapies. As hospital networks, pharmaceutical producers, and distribution channels recalibrate their positions, gatifloxacin’s role across multiple indications and delivery formats becomes increasingly central for clinicians and supply chain decision-makers.

Scope & Segmentation Overview

This report delivers an in-depth analysis across all critical segments and regions, providing focused intelligence for strategic planning:

  • Product Types: Injectable (200 mg, 400 mg), Ophthalmic Drops (0.3%), Oral Tablets (200 mg, 400 mg)
  • Applications: Dermal Infections, Ocular Infections, Respiratory Tract Infections, Urinary Tract Infections
  • Routes of Administration: Ophthalmic, Oral, Parenteral
  • Distribution Channels: Hospital Pharmacy (Private, Public), Online Pharmacy, Retail Pharmacy (Chain, Independent)
  • Geographies: Americas (including United States, Canada, Brazil, Mexico, Argentina), Europe/Middle East/Africa (covering United Kingdom, Germany, and more), Asia-Pacific (notably China, India, Japan, Australia, and Southeast Asia)
  • Key Industry Players: Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Cadila Healthcare Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH

Attention is given to novel technologies such as digitalized clinical trial management, advanced pharmacokinetic profiling for targeted delivery, and personalized diagnostics to inform prescription practices. Regional factors are addressed through analysis of reimbursement models and infrastructure diversity across developed and emerging markets.

Key Takeaways for Decision-Makers

  • Formulation innovation, including ophthalmic and injectable options, drives clinician adoption by addressing targeted clinical needs and responding to heightened safety requirements.
  • Personalized diagnostics and antimicrobial stewardship programs are establishing new protocols for the effective use of gatifloxacin, tightening alignment between prescription and pathogen identification.
  • Distribution patterns shift with the rise of online pharmacies and digital healthcare delivery models, increasing competition within traditional and virtual retail channels.
  • Collaborations, such as those between pharmaceutical manufacturers and diagnostic technology providers, are accelerating market access and maximizing clinical value for both acute and chronic care settings.
  • Regional adaptation is crucial; differentiated procurement strategies and market entry plans are necessary to align with diverse policy and reimbursement landscapes across continents.

Tariff Impact: Adjustments Affecting Supply Chain Decisions

The implementation of new tariff regulations in the US from 2025 has created cost headwinds in the gatifloxacin supply chain. Increased duties on imported active ingredients and excipients have prompted manufacturers to reshape sourcing decisions and consider domestic manufacturing partnerships. Hospitals and pharmacies are re-evaluating procurement practices, prioritizing inventory optimization and risk-sharing agreements to maintain stability. These shifts highlight the importance of flexibility and scenario planning in managing long-term pricing and supply continuity.

Methodology & Data Sources

Our analysis employs a multi-layered research approach, integrating insights from interviews with industry leaders, in-depth examination of regulatory filings, and comprehensive review of clinical trial and trade data. Proprietary segmentation models and triangulated validation ensure accuracy and relevance throughout, providing a reliable basis for decision-making.

Why This Report Matters for Senior Leaders

  • Enables direct benchmarking of competitors and evaluation of technology-driven opportunities within product and regional segments.
  • Guides stakeholders in anticipating the regulatory, economic, and supply-side shifts most likely to influence their near- and long-term commercial decisions.
  • Delivers actionable insights that support procurement optimization, alliance formation, and the scaling of future-ready distribution channels.

Conclusion

The gatifloxacin market is shaped by regulatory changes, clinical innovation, and shifting supply chains. Strategic analysis and targeted adaptation will empower industry leaders to stay ahead as the sector continues its transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gatifloxacin Market, by Product Type
8.1. Introduction
8.2. Injectable
8.2.1. 200 Mg
8.2.2. 400 Mg
8.3. Ophthalmic Drops
8.3.1. 0.3%
8.4. Oral Tablets
8.4.1. 200 Mg
8.4.2. 400 Mg
9. Gatifloxacin Market, by Application
9.1. Introduction
9.2. Dermal Infections
9.3. Ocular Infections
9.4. Respiratory Tract Infections
9.5. Urinary Tract Infections
10. Gatifloxacin Market, by Route of Administration
10.1. Introduction
10.2. Ophthalmic
10.3. Oral
10.4. Parenteral
11. Gatifloxacin Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.2.1. Private Hospital Pharmacy
11.2.2. Public Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.4.1. Chain Retail Pharmacy
11.4.2. Independent Retail Pharmacy
12. Americas Gatifloxacin Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Gatifloxacin Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Gatifloxacin Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sun Pharmaceutical Industries Limited
15.3.2. Dr. Reddy's Laboratories Limited
15.3.3. Cipla Limited
15.3.4. Lupin Limited
15.3.5. Aurobindo Pharma Limited
15.3.6. Torrent Pharmaceuticals Limited
15.3.7. Cadila Healthcare Limited
15.3.8. Viatris Inc.
15.3.9. Teva Pharmaceutical Industries Ltd
15.3.10. Sandoz International GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GATIFLOXACIN MARKET MULTI-CURRENCY
FIGURE 2. GATIFLOXACIN MARKET MULTI-LANGUAGE
FIGURE 3. GATIFLOXACIN MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GATIFLOXACIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GATIFLOXACIN MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GATIFLOXACIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GATIFLOXACIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GATIFLOXACIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GATIFLOXACIN MARKET SIZE, BY 0.3%, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GATIFLOXACIN MARKET SIZE, BY 200 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GATIFLOXACIN MARKET SIZE, BY 400 MG, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GATIFLOXACIN MARKET SIZE, BY DERMAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GATIFLOXACIN MARKET SIZE, BY OCULAR INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GATIFLOXACIN MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GATIFLOXACIN MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GATIFLOXACIN MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GATIFLOXACIN MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GATIFLOXACIN MARKET SIZE, BY PRIVATE HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GATIFLOXACIN MARKET SIZE, BY PUBLIC HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GATIFLOXACIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GATIFLOXACIN MARKET SIZE, BY CHAIN RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GATIFLOXACIN MARKET SIZE, BY INDEPENDENT RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES GATIFLOXACIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 59. CANADA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 60. CANADA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 61. CANADA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. CANADA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. CANADA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. MEXICO GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 112. GERMANY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. GERMANY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 115. GERMANY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 116. GERMANY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. GERMANY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. GERMANY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 120. GERMANY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 121. FRANCE GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 125. FRANCE GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FRANCE GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. FRANCE GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 129. FRANCE GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. ITALY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ITALY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 141. ITALY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 142. ITALY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 143. ITALY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. ITALY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. ITALY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ITALY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 147. ITALY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 148. SPAIN GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. SPAIN GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 151. SPAIN GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 152. SPAIN GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. SPAIN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. SPAIN GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SPAIN GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 156. SPAIN GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 184. DENMARK GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. DENMARK GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 187. DENMARK GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 188. DENMARK GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. DENMARK GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. DENMARK GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. DENMARK GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 192. DENMARK GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 193. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 202. QATAR GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 203. QATAR GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 204. QATAR GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 205. QATAR GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 206. QATAR GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. QATAR GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. QATAR GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. QATAR GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. QATAR GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 211. FINLAND GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. FINLAND GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 213. FINLAND GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 214. FINLAND GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 215. FINLAND GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. FINLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. FINLAND GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. FINLAND GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. FINLAND GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 220. SWEDEN GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SWEDEN GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 229. NIGERIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. NIGERIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 238. EGYPT GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. EGYPT GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 241. EGYPT GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 242. EGYPT GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. EGYPT GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. EGYPT GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. EGYPT GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 246. EGYPT GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 247. TURKEY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 248. TURKEY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 249. TURKEY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 250. TURKEY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 251. TURKEY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. TURKEY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 253. TURKEY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. TURKEY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 255. TURKEY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 256. ISRAEL GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. ISRAEL GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 265. NORWAY GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. NORWAY GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 267. NORWAY GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 268. NORWAY GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 269. NORWAY GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. NORWAY GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 271. NORWAY GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. NORWAY GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 273. NORWAY GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 274. POLAND GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. POLAND GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 276. POLAND GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 277. POLAND GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 278. POLAND GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. POLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 280. POLAND GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. POLAND GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 282. POLAND GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 292. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC GATIFLOXACIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 302. CHINA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. CHINA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 304. CHINA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 305. CHINA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 306. CHINA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. CHINA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 308. CHINA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 309. CHINA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 310. CHINA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 311. INDIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. INDIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 313. INDIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 314. INDIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 315. INDIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. INDIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 317. INDIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. INDIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 319. INDIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 320. JAPAN GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. JAPAN GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 322. JAPAN GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 323. JAPAN GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 324. JAPAN GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. JAPAN GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 326. JAPAN GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. JAPAN GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 328. JAPAN GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 329. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 331. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 332. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 333. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 335. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 338. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 340. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 341. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 342. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 343. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 344. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 346. SOUTH KOREA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 347. INDONESIA GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 348. INDONESIA GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 349. INDONESIA GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA GATIFLOXACIN MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA GATIFLOXACIN MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 356. THAILAND GATIFLOXACIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 357. THAILAND GATIFLOXACIN MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 358. THAILAND GATIFLOXACIN MARKET SIZE, BY OPHTHALMIC DROPS, 2018-2030 (USD MILLION)
TABLE 359. THAILAND GATIFLOXACIN MARKET SIZE, BY ORAL TABLETS, 2018-2030 (USD MILLION)
TABLE 360. THAILAND GATIFLOXACIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 361. THAILAND GATIFLOXACIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 362. THAILAND GATIFLOXACIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gatifloxacin market report include:
  • Sun Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Lupin Limited
  • Aurobindo Pharma Limited
  • Torrent Pharmaceuticals Limited
  • Cadila Healthcare Limited
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 348.23 Million
Forecasted Market Value ( USD ) by 2030 $ 440.68 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gatifloxacin (CAS 112811-59-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Gatifloxacin (CAS 112811-59-3) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Aminoglycosides Market by Product Type, Route Administration, Application, Distribution Channel, Formulation - Global Forecast to 2030 - Product Image

Aminoglycosides Market by Product Type, Route Administration, Application, Distribution Channel, Formulation - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Balofloxacin Market by Indication, Dosage Form, Distribution Channel, End User, Formulation Type, Patient Demographics - Global Forecast to 2030 - Product Image

Balofloxacin Market by Indication, Dosage Form, Distribution Channel, End User, Formulation Type, Patient Demographics - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Peptide Antibiotics Market Size, Share & Trends Analysis Report By Disease (Skin Infection, HABP/VABP), By Route of Administration (Injectable, Oral), By Product, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030 - Product Image

Aminoglycosides Market Size, Share & Trends Analysis Report by Product (Neomycin, Tobramycin, Gentamicin), Route of Administration (Injectables, Feed, Intra-mammary), Application (Veterinary, Skin Infection), Region, with Growth Forecasts, 2025-2030

  • Report
  • 105 Pages
  • Global
From

About the Gatifloxacin Market

Gatifloxacin is an antibiotic used to treat a variety of bacterial infections. It belongs to the class of drugs known as fluoroquinolones, which work by inhibiting the growth of bacteria. Gatifloxacin is used to treat respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other bacterial infections. It is also used to treat certain sexually transmitted diseases. Gatifloxacin is available in both oral and intravenous forms. Gatifloxacin is generally well tolerated, but it can cause side effects such as nausea, vomiting, diarrhea, and headache. It can also cause serious side effects such as tendon rupture, liver damage, and increased risk of tendinitis and tendon rupture. Gatifloxacin is available in generic form and is also sold under the brand names Tequin, Gatiflo, and Zagam. It is manufactured by several pharmaceutical companies, including GlaxoSmithKline, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.